pirinixic acid has been researched along with Cancer of Lung in 3 studies
pirinixic acid: structure
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Wu, L | 1 |
Wang, W | 1 |
Dai, M | 1 |
Li, H | 1 |
Chen, C | 1 |
Wang, D | 1 |
Skrypnyk, N | 1 |
Chen, X | 1 |
Hu, W | 1 |
Su, Y | 1 |
Mont, S | 1 |
Yang, S | 1 |
Gangadhariah, M | 1 |
Wei, S | 1 |
Falck, JR | 1 |
Jat, JL | 1 |
Zent, R | 1 |
Capdevila, JH | 1 |
Pozzi, A | 1 |
Avis, I | 1 |
Martínez, A | 1 |
Tauler, J | 1 |
Zudaire, E | 1 |
Mayburd, A | 1 |
Abu-Ghazaleh, R | 1 |
Ondrey, F | 1 |
Mulshine, JL | 1 |
3 other studies available for pirinixic acid and Cancer of Lung
Article | Year |
---|---|
PPARα ligand, AVE8134, and cyclooxygenase inhibitor therapy synergistically suppress lung cancer growth and metastasis.
Topics: Animals; Antineoplastic Agents; Benzoates; Bezafibrate; Cell Line, Tumor; Cell Movement; Cell Prolif | 2019 |
PPARα activation can help prevent and treat non-small cell lung cancer.
Topics: Animals; Arachidonic Acids; Bezafibrate; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Prol | 2014 |
Inhibitors of the arachidonic acid pathway and peroxisome proliferator-activated receptor ligands have superadditive effects on lung cancer growth inhibition.
Topics: Acetophenones; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Arachidonic Acid; Caspases | 2005 |